written by reader Looking for info on Manny Backus “Boston Biotech” Stock

by jstep8856 | March 11, 2014 4:20 pm

Hello Travis
Just saw a teaser about a ”Boston Biotech” stock that is poised to show 400 to 700% profits this year from Penny Stock gurus Manny Backus[1]. Can you ”thinkolate” this one. Sounds pretty promising!
Thanks for your thoughts. They’re always appreciated!

Endnotes:
  1. Manny Backus: https://www.stockgumshoe.com/tag/manny-backus/

Source URL: https://www.stockgumshoe.com/2014/03/microblog-looking-for-info-on-manny-backus-boston-biotech-stock/


4 responses to “written by reader Looking for info on Manny Backus “Boston Biotech” Stock”

  1. cajungun13 says:

    Also have seen this one a lot..would love to know the ticker!

  2. arch1 says:

    Paul ,try BSX Boston scientific. I have seen that teased before but I don’t know of ant new developments..

  3. Andy Bell says:

    Jeff,
    Greenfire67 is 100% correct on Ziopharm. Manny Backus wrote up a major article
    December 15, 2013 on it which you can read. He was promoting this stock on his Conscensus Picks which I still subscribe to. At that time he was advising subscribers
    to buy below $4 and to sell at $9. The drug in question is AD-RTS-IL-12 which is in
    phase two trials as of December 15, 2013. Also, the two partners that Ziopharm
    is working with are Intrexon (XON) and Mesoblast. The insider guy in the tease that
    bought 2,8577,000 shares for a cool ten million is Randall Kirk. They also issued 14.3 million shares last March which caused shares to plummet to $3.50 a stub. The title
    of the article is “Ziopharm: Finally a Cure in the War on Cancer?” which you can access
    by typing in ZIOP on the Finviz site, and scrolling down for this article below the stock
    chart. I’m not sure but Dr. Karma might have something to say about it in the Benitech
    blog.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.